Lamivudine Tablet, Film Coated
Product Images NDC 60687-720
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lamivudine (NDC 60687-720). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
150 mg Lamivudine Tablet Blister (Blister)
150 mg Lamivudine Tablets Carton (Carton)
This is a description of a drug package containing Lamivudine tablets. The tablets are film-coated, with each tablet containing 150 mg of the active ingredient. There are 30 tablets in the package, which is sealed and designed to keep the product at a temperature range of 20-25°C (68-77°F). The product is distributed by American Health Packaging in Columbus, Ohio. The recommended dosage is not provided in the package, and the customer can refer to the package insert for prescribing information. The package indicates that the drug product is from NDC 1 80505-251 and is for exclusive use by authorized personnel.*
Figure 1. Virologic Response Through Week 48, Epv20001 (intent-to-treat) (Figure1)
Structural Formula (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.